GlassScriptPhysician profile
Derek W Lahm
NPI 1720718141
$2,097.99
in general payments reported to CMS, 2019-2025
8 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $488 · 2023: $380 · 2024: $991 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,510 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,509.98 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $643.66 | 2022-2025 | Hydrus Microstent, Clareon, Voyager Dslt |
| Genentech USA, INC. | $436.31 | 2023-2024 | Vabysmo |
| Sight Sciences, INC. | $388.55 | 2022-2024 | Omni Surgical System |
| Abbvie INC. | $246.90 | 2022-2025 | |
| Amgen INC. | $147.05 | 2024-2025 | Tepezza |
| Alimera Sciences, INC. | $86.15 | 2024 | Iluvien, Yutiq |
| Coherus Oncology, INC. | $78.31 | 2022 | |
| Horizon Therapeutics Plc | $71.06 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Lahm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.